InvestorsHub Logo
Followers 5
Posts 784
Boards Moderated 0
Alias Born 07/19/2006

Re: None

Friday, 11/10/2023 10:53:01 AM

Friday, November 10, 2023 10:53:01 AM

Post# of 2827
Mozobil sales down 23% last quarter. Lots of generics. Can BLRX really compete in this environment even given that they have a better product? I thought Rolvedon could with Nualesta and boy was i wrong $ASRT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLRX News